Phreesia
PHR
10.50
+0.25
+2.44%
Phreesia
US · PHR
#3570 by market cap
Listed 2019
10.50
+0.25
+2.44%
Live - 5344 symbols - heartbeat 529s ago
· 2026-10-08 04:23
Pre-market
10.70
+1.90%
After-hours
10.50
0.00%
- Market cap
- 651.74M
- P/E (TTM)i
- 58.33
- P/Bi
- 1.75
- EPSi
- 0.04
- Div yieldi
- 0.00%
- 52W posi
- 17%
Reader sentiment
Are you bullish or bearish on PHR?
Anonymous reader poll. Unscientific, not investment advice.
Recent news
-
William Blair Maintains Phreesia(PHR.US) With Buy RatingMarket Newswire · 2026/10/3
-
Rating change
D.A. Davidson Maintains Phreesia(PHR.US) With Buy Rating, Cuts Target Price to $13Market Newswire · 2026/9/4
-
Rating change
A Quick Look at Today's Ratings for Phreesia(PHR.US), With a Forecast Between $14 to $19Market Newswire · 2026/9/3
-
Raymond James Downgrades Phreesia(PHR.US) to Hold Rating, Cuts Target Price to $12Market Newswire · 2026/9/8
-
Rating change
BMO Capital Maintains Phreesia(PHR.US) With Buy Rating, Maintains Target Price $14Market Newswire · 2026/6/22
-
Rating change
Barclays Maintains Phreesia(PHR.US) With Hold Rating, Maintains Target Price $10Market Newswire · 2026/6/15
-
Rating change
Needham Maintains Phreesia(PHR.US) With Buy Rating, Maintains Target Price $14Market Newswire · 2026/8/31
-
RBC Capital Maintains Phreesia(PHR.US) With Buy Rating, Maintains Target Price $19Market Newswire · 2026/10/7
-
Company notice
Tecmira Holdings: Wellmira and Arteryex have demonstrated the effectiveness of multidisciplinary collaboration leveraging PHR.JPX · 2026/6/1
-
Analysts Are Bullish on Top Healthcare Stocks: Alto Neuroscience, Inc. (ANRO), Phreesia (PHR)TipRanks · 2026/10/3
-
Rating change
A Quick Look at Today's Ratings for Phreesia(PHR.US), With a Forecast Between $12 to $16Market Newswire · 2026/5/29
-
Company notice
JMDC: Mitsubishi UFJ Bank, Omron, and JMDC are collaborating to promote regular blood pressure monitoring among all approximately 30,000 employees—leveraging PHR (Personal Health Record) technology to advance both self-care and advanced health management.JPX · 2026/6/30
-
Rating change
J.P. Morgan Maintains Phreesia(PHR.US) With Hold Rating, Maintains Target Price $14Market Newswire · 2026/6/25
-
Rating change
CCORF Maintains Phreesia(PHR.US) With Buy Rating, Maintains Target Price $16Market Newswire · 2026/8/12
-
Company notice
Alfresa Holdings: We are conducting a demonstration project to improve dietary habits through product recommendations and health support leveraging PHR data, with the aim of extending the healthy life expectancy of Tsukuba City residents and preventing lifestyle-related diseases.JPX · 2026/8/21
-
Company notice
JMDC: JMDC has confirmed that the practice of recording measurements from body composition analyzers and blood pressure monitors in a personal health record (PHR) may contribute to improvements in body weight and blood pressure.JPX · 2026/9/18
-
D.A. Davidson Maintains Phreesia(PHR.US) With Buy Rating, Maintains Target Price $13Market Newswire · 2026/9/4
-
Rating change
Truist Financial Maintains Phreesia(PHR.US) With Hold RatingMarket Newswire · 2026/9/3
-
Company notice
Techmatrix: PSP: Yokohama Municipal Minato Red Cross Hospital has adopted the PHR app "NOBORI."JPX · 2026/6/1
-
Rating change
Analysts Have Conflicting Sentiments on These Healthcare Companies: Phreesia (PHR), Alpha Tau (DRTS) and Fortrea Holdings Inc. (FTRE)TipRanks · 2026/9/3
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-10-08 04:23:07 · For reference only, not investment advice and not tailored to your situation.